Top

Published in:

03-11-2022 | Meningococcus | Obituary

Obituary Prof. Ulrich Vogel, MD 1964–2022: a scientific mentor and expert in infection prevention and control

Authors: Oliver Kurzai, Heike Claus, Thien-Trí Lâm

Published in: Medical Microbiology and Immunology | Issue 1/2023

Excerpt

With great sadness we write on the passing of our colleague, mentor and friend Prof. Ulrich Vogel, MD who died after a serious illness on October 4, 2022. …

Vogel U, Claus H (2003) Molecular epidemiology of Neisseria meningitidis. Front Biosci 8:e14-22CrossRefPubMed

Vogel U, Claus H, Frosch M (2000) Rapid serogroup switching in Neisseria meningitidis. N Engl J Med 342(3):219–220CrossRefPubMed

Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, Costello CE, Ngampasutadol J, Vogel U, Granoff DM, Ram S (2006) The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177(1):501–510CrossRefPubMed

Harmsen D, Claus H, Witte W, Rothgänger J, Claus H, Turnwald D, Vogel U (2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41(12):5442–5448CrossRefPubMedPubMedCentral

Title: Obituary Prof. Ulrich Vogel, MD 1964–2022: a scientific mentor and expert in infection prevention and control
Authors: Oliver Kurzai
Heike Claus
Thien-Trí Lâm
Publication date: 03-11-2022
Publisher: Springer Berlin Heidelberg
Keyword: Meningococcus
Published in: Medical Microbiology and Immunology / Issue 1/2023
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI: https://doi.org/10.1007/s00430-022-00751-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Acinetobacter baumannii reinforces the pathogenesis by promoting IL-17 production in a mouse pneumonia model

Reduced neutralization against Delta, Gamma, Mu, and Omicron BA.1 variants of SARS-CoV-2 from previous non-Omicron infection

In vitro and in vivo therapeutic antileishmanial potential of ellagic acid against Leishmania donovani in murine model

SARS-CoV-2 infection in the context of Kawasaki disease and multisystem inflammatory syndrome in children

A high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17 T cell production

Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials